Trials / Completed
CompletedNCT00067470
Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- BioMarin Pharmaceutical · Industry
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the ability of rhASB versus placebo to enhance endurance in patients with Mucopolysaccharidosis VI (MPS VI), as evidenced by an increase in the number of meters walked in the 12 minute walk test at Week 24 compared with baseline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | N-acetylgalactosamine 4-sulfatase |
Timeline
- Start date
- 2003-09-01
- Completion
- 2004-03-01
- First posted
- 2003-08-25
- Last updated
- 2009-12-24
- Results posted
- 2009-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00067470. Inclusion in this directory is not an endorsement.